Zorana Bogicevic

Mrs. Zorana Bogicevic

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 March 2021 in Molecular and Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
NTNebojša M. Tasić
Nebojša M. Tasić
Vladimir JakovljevicVladimir Jakovljevic
Vladimir Jakovljevic
MMMiroslav Mitrovic
Miroslav Mitrovic
BDBoris Djindjic
Boris Djindjic
TDTasic Danijela
Tasic Danijela
TTTamara R Nikolic Turnic
Tamara R Nikolic Turnic

23 August 2023 in Healthcare
Verified
Journal Article
Open access
PDF file
AŠArmin Šljivo
Armin Šljivo
AMAhmed Mulać
Ahmed Mulać
ADAmina Džidić-Krivić
Amina Džidić-Krivić
KIKatarina Ivanovic
Katarina Ivanovic
DRdragana dragan radoicic
dragana dragan radoicic
STSanja Tomić
Sanja Tomić
Background: Chest pain represents a prevalent complaint in emergency departments (EDs), where the precise differentiation between acute coronary syndrome and alternative conditions assumes paramount significance. This pilot study aimed to assess the HEART score’s implementation in West Balkan EDs. Methods: A retrospective analysis was performed on a prospective cohort comprising patients presenting with chest pain admitted to EDs in Sarajevo, Zenica, and Belgrade between July and December 2022. Results: A total of 303 patients were included, with 128 classified as low-risk based on the HEART score and 175 classified as moderate-to-high-risk. The low-risk patients exhibited younger age and a lower prevalence of cardiovascular risk factors. Laboratory and anamnestic findings revealed higher levels of C-reactive protein, ALT, and creatinine, higher rates of moderately to highly suspicious chest pain history, a greater number of cardiovascular risk factors, and elevated troponin levels in moderate-to-high-risk patients. Comparatively, among patients with a low HEART score, 2.3% experienced MACE, whereas those with a moderate-to high-risk HEART score had a MACE rate of 10.2%. A moderate-to-high-risk HEART score demonstrated a sensitivity of 91.2% (95%CI 90.2–93.4%) and specificity of 46.5% (95%CI 39.9–48.3%) for predicting MACE. Conclusion: This pilot study offers preliminary insights into the integration of the HEART score within the emergency departments of the West Balkan region.

6 April 2022 in Diagnostics
Verified
Journal Article
Open access
PDF file
NTNebojša M. Tasić
Nebojša M. Tasić
TDTasic Danijela
Tasic Danijela
ZBZorana Bogicevic
Zorana Bogicevic
MFMarko Filipovic
Marko Filipovic
AMArsic Milan
Arsic Milan
Vladimir JakovljevicVladimir Jakovljevic
Vladimir Jakovljevic
Background: The purpose of this study was to compare home and office BP in the adjustment of antihypertensive treatment. Methods: This study was an open, prospective, noninterventional, multicenter clinical trial that occurred between July 2019 and February 2020, in 34 cities in the territory of the Republic of Serbia, which monitored 1581 participants for 6 months. Depending on the used blood pressure monitoring method used, all patients were divided into control (office BP monitoring) and experimental (home BP telemonitoring) groups. We collected anamnestic data and data about systolic blood pressure (SP), in mmHg, diastolic blood pressure (DP), in mmHg, and heart rate (HR), in beats/minute, from all patients. Results: SP values were significantly different at baseline, and at the second, third, and fourth visits between the two tested groups. Home and office BP decreased significantly (p < 0.000) during the 6-month follow-up. We observed a statistically significant influence of the presence of diabetes mellitus and dyslipidemia on the dynamics of differences between SP monitoring values. Conclusions: Our study suggests that novel technologies in BP monitoring can be excellent alternatives for BP assessment in hypertensive patients with other cardiovascular risk factors such as diabetes and dyslipidemia.

24 April 2026 in Medicina
Verified
Journal Article
Open access
PDF file
SOSladjana Djordje Božović - Ogarević
Sladjana Djordje Božović - Ogarević
ZBZoran Bukumiric
Zoran Bukumiric
DKDejan Kojic
Dejan Kojic
MBMilovan Bojic
Milovan Bojic
AGAleksandra Grbović
Aleksandra Grbović
NTNebojša M. Tasić
Nebojša M. Tasić
Background and Objectives: Idiopathic ventricular arrhythmias commonly occur in patients without structural heart disease and most often present as premature ventricular contractions (PVCs). Although generally considered benign, a high PVC burden may cause symptoms, reduce quality of life, and lead to reversible PVC-induced cardiomyopathy. This study aimed to evaluate long-term outcomes after radiofrequency catheter ablation of idiopathic outflow tract PVCs. Materials and Methods: This single-center retrospective study included 101 patients with idiopathic PVCs who underwent radiofrequency catheter ablation. PVC burden and clinical outcomes were assessed at baseline and during follow-up at 3 months, 12 months, and 5 years. Procedural success, predictors of success, and changes in antiarrhythmic drug therapy were analyzed. Results: During follow-up, a marked reduction in PVC burden was observed compared with baseline values. The median PVC burden decreased from 21.89% at baseline to 0.79% at 3 months, 0.23% at 12 months, and 0.09% at the 5-year follow-up after ablation. Acute procedural success was achieved in 88.1% of patients. Long-term success at 5 years was observed in 80.2% of patients. The use of antiarrhythmic drugs decreased during follow-up. Left ventricular ejection fraction remained stable, with no significant difference between baseline and 5-year values. Monomorphic PVC morphology and procedural success at 12 months were identified as independent predictors of long-term success. Conclusions: Radiofrequency catheter ablation provides effective and sustained reduction in PVC burden in patients with idiopathic outflow tract PVCs, with high acute success rates, durable long-term outcomes, and reduced reliance on antiarrhythmic drug therapy.